FDA Concludes Scientific Review Pilot Project with AI and Prepares for Transversal Implementation by June 2025

The recent completion of the FDA's artificial intelligence-supported pilot project marks an important step in the modernization of scientific review processes. With the promise of speeding up evaluations and reducing repetitive tasks, the FDA plans to implement generative AI across the board by June 2025.